Zydus Lifesciences Reports Q4FY26 Results; EBITDA Margin Expands To 33.7%, ...

Zydus Lifesciences reported Q4FY26 consolidated revenue growth of 16.2 per cent YoY to Rs 7,587 cror...

Parag Parikh Flexi Cap Fund Increased Stake in This Pharma Company; Board t...

Zydus Lifesciences informed exchanges that its board will consider a proposal for buyback of fully p...

Overnight Digest: Shares to Keep an Eye on March 13, 2026...

Stay updated on March 13, 2026, market movements as NIFTY 50 and BSE Sensex closed lower amid Middle...

Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Am...

In a year, the stock has declined by 8 per cent while in last 3 years the stock has jumped by 151 pe...

Watch Out For These Penny Stocks Locked In The Upper Circuit on April 09, 2...

This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets wi...

Zydus group Company Invests in Illexcor for Sickle Cell Treatment; Stock Ga...

New Drug Launch: Transforming Cardiometabolic Care in India...

The company continues to strengthen its presence in the cardiometabolic care segment, addressing the...

Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partners...

FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance...

This pharma company's shares surged to a new 52-week high after receiving f...

The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger ...